Silvermedia sp. z o.o.

Buma Square Business Park, Wadowicka 6, 30-415 Krakow

Telephone +48 12 3760250
Fax +48 12 3975552


Hall map

MEDICA 2016 hall map (Hall 15): stand D32

Fairground map

MEDICA 2016 fairground map: Hall 15

Our range of products

Product categories

  • 06  Information and communication technology
  • 06.03  eHealth, telemedicine / telematics / telemetry

eHealth, telemedicine / telematics / telemetry

  • 06  Information and communication technology
  • 06.03  eHealth, telemedicine / telematics / telemetry
  • 06.03.07  Teleconsult systems, telemonitoring / AAL

Teleconsult systems, telemonitoring / AAL

Our products

Product category: eHealth, telemedicine / telematics / telemetry, Teleconsult systems, telemonitoring / AAL

Selected Solutions

Silvermedia offers IT solutions tailored to meet the individual needs of customers. 
Our systems are used by:

  • Health care centres
  • Research units
  • Medical schools
  • Public administration
  • Medical equipment companies

It is a modular platform for telehealth services. Silvermedic platform serves as the basis for most IT solutions developed by Silvermedia.
Silvermedic software is made up of two basic components:

Web applications: systems of collecting, processing and providing medical data
Client applications: desktop and mobile applications (for smartphones, tablets and portable medical equipment)
The aim of Silvermedia platform is to provide easy access to medical data via mobile devices. It allows clinicians to analyse test results and consult patients about the treatment from any place in the world.

find out more » 

Our team of specialists in biocybernetics devises original algorithms which help to diagnose various kinds of diseases. 
Since these algorithms help clinicians to define the proper state of functioning of the body, it is possible to perform remote diagnosis of any abnormalities.

Today, our algorithms are most commonly used in:

  • Cardiology, where they support ECG analysis and help to diagnose different heart diseases;
  • Audiology, where they enable remote hearing assessment of children and infants (e.g. ABR);
  • Allergology, where they facilitate diagnosis of asthma and allergy on the basis of medical statistics;
  • Neurology, where they help to evaluate the degree of neurodegenerative diseases and support clinicians in the assessment of treatment results.

More Less

About us

Company details

We actively partner with European scientific institutions.

We take part in European Commission programmes which support the development of IT and innovation in the healthcare sector. 
Silvermedia’s products have been widely recognised and acknowledged by international institutions as the high quality and leading-edge solutions.

The Seventh Framework Programme for Research and Technological Development is a key EU research financing instrument. We have been a regular technological partner of the Programme, responsible for delivering telehealth IT solutions.
Over the last two years we participated in seven international consortia applying for FP7 financing. We are partnering with the most renowned scientific organisations in Europe and the US such as Harvard University, Politecnico di Milano and the Medical University of Freiburg.

We have received funds to implement the project “Design of an Innovative Device for Remote Audiology Screening”, awarded from Measure 1.4 of the Innovative Economy Operational Programme 2007-2013. 
The funding received enabled us to develop an IT system used by the World Hearing Centre in Kajetany to detect hearing defects in children. The screening scheme, active between March and June 2010, covered 90,000 children from more than 45,000 schools from all over Poland.

We have received funds to implement the project „Development of a Screening System – adaptation to the research in the field of allergology and cardiology",  awarded from Measure 1.4 of the Innovative Economy Operational Programme 2007-2013. 
The funding received enabled us to develop a product that will support screening programs in various fields of medicine, at the beginning in allergy and cardiology.

The company’s international development has received co-financing under the heading of Measure 6.1, the Innovative Economy Operational Programme 2007-2013. The funding enables us to achieve our strategic goal: expand onto new markets with a portfolio of IT systems dedicated for the healthcare sector.

More Less